Prot #GA29145: An Open-Label Extension and Safety Monitoring Study of Patients With Moderately to Severely Active Crohn’s Disease Previously Enrolled In The Etrolizumab Phase III Protocol GA29144

Project: Research project

Project Details

StatusActive
Effective start/end date4/12/167/15/21

Funding

  • Quintiles, Inc. (Prot #GA29145)
  • Genentech, Inc. (Prot #GA29145)